Pds Biotechnology Corp Stock Market Value
| PDSB Stock | USD 2.17 0.08 3.83% |
| Symbol | PDS |
PDS Biotechnology Corp Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of PDS Biotechnology. If investors know PDS will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about PDS Biotechnology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.17) | Return On Assets (0.40) | Return On Equity (1.28) |
The market value of PDS Biotechnology Corp is measured differently than its book value, which is the value of PDS that is recorded on the company's balance sheet. Investors also form their own opinion of PDS Biotechnology's value that differs from its market value or its book value, called intrinsic value, which is PDS Biotechnology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because PDS Biotechnology's market value can be influenced by many factors that don't directly affect PDS Biotechnology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between PDS Biotechnology's value and its price as these two are different measures arrived at by different means. Investors typically determine if PDS Biotechnology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, PDS Biotechnology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
PDS Biotechnology 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to PDS Biotechnology's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of PDS Biotechnology.
| 10/26/2024 |
| 11/25/2024 |
If you would invest 0.00 in PDS Biotechnology on October 26, 2024 and sell it all today you would earn a total of 0.00 from holding PDS Biotechnology Corp or generate 0.0% return on investment in PDS Biotechnology over 30 days. PDS Biotechnology is related to or competes with Mereo BioPharma, Terns Pharmaceuticals, Inozyme Pharma, Hookipa Pharma, Enveric Biosciences, Ocean Biomedical, and X4 Pharmaceuticals. PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer ... More
PDS Biotechnology Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure PDS Biotechnology's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess PDS Biotechnology Corp upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.15) | |||
| Maximum Drawdown | 31.83 | |||
| Value At Risk | (6.76) | |||
| Potential Upside | 7.67 |
PDS Biotechnology Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for PDS Biotechnology's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as PDS Biotechnology's standard deviation. In reality, there are many statistical measures that can use PDS Biotechnology historical prices to predict the future PDS Biotechnology's volatility.| Risk Adjusted Performance | (0.08) | |||
| Jensen Alpha | (0.78) | |||
| Total Risk Alpha | (1.34) | |||
| Treynor Ratio | (0.35) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of PDS Biotechnology's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
PDS Biotechnology Corp Backtested Returns
PDS Biotechnology Corp maintains Sharpe Ratio (i.e., Efficiency) of -0.1, which implies the firm had a -0.1% return per unit of standard deviation over the last 3 months. PDS Biotechnology Corp exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check PDS Biotechnology's Market Risk Adjusted Performance of (0.34), risk adjusted performance of (0.08), and Coefficient Of Variation of (846.13) to confirm the risk estimate we provide. The company holds a Beta of 1.68, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, PDS Biotechnology will likely underperform. At this point, PDS Biotechnology Corp has a negative expected return of -0.5%. Please make sure to check PDS Biotechnology's kurtosis, as well as the relationship between the day median price and relative strength index , to decide if PDS Biotechnology Corp performance from the past will be repeated at future time.
Auto-correlation | 0.23 |
Weak predictability
PDS Biotechnology Corp has weak predictability. Overlapping area represents the amount of predictability between PDS Biotechnology time series from 26th of October 2024 to 10th of November 2024 and 10th of November 2024 to 25th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of PDS Biotechnology Corp price movement. The serial correlation of 0.23 indicates that over 23.0% of current PDS Biotechnology price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.23 | |
| Spearman Rank Test | -0.15 | |
| Residual Average | 0.0 | |
| Price Variance | 0.17 |
PDS Biotechnology Corp lagged returns against current returns
Autocorrelation, which is PDS Biotechnology stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting PDS Biotechnology's stock expected returns. We can calculate the autocorrelation of PDS Biotechnology returns to help us make a trade decision. For example, suppose you find that PDS Biotechnology has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
PDS Biotechnology regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If PDS Biotechnology stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if PDS Biotechnology stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in PDS Biotechnology stock over time.
Current vs Lagged Prices |
| Timeline |
PDS Biotechnology Lagged Returns
When evaluating PDS Biotechnology's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of PDS Biotechnology stock have on its future price. PDS Biotechnology autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, PDS Biotechnology autocorrelation shows the relationship between PDS Biotechnology stock current value and its past values and can show if there is a momentum factor associated with investing in PDS Biotechnology Corp.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether PDS Biotechnology Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of PDS Biotechnology's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Pds Biotechnology Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Pds Biotechnology Corp Stock:Check out PDS Biotechnology Correlation, PDS Biotechnology Volatility and PDS Biotechnology Alpha and Beta module to complement your research on PDS Biotechnology. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
PDS Biotechnology technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.